Reducing CV Risk in T2D With Electronic Messaging Intervention

Share this content:
Study participants received either a phone call or electronic message with appointment reminders and health information.
Study participants received either a phone call or electronic message with appointment reminders and health information.

HealthDay News — For patients with type 2 diabetes, an electronic messaging intervention is effective for reducing cardiovascular risk, according to a study published online in the Journal of Clinical Nursing.

Ronghua Fang, RN, and Xuexue Deng, RN, from the West China Hospital Sichuan University in Chengdu, conducted a convenience sample study with randomized group assignment to examine the effectiveness of an electronic messaging support service for management of cardiovascular risk factors in patients with type 2 diabetes. Participants completed surveys and underwent physical and laboratory evaluations, and were randomized to either receipt of electronic messages or a phone call. Intervention patients received appointment reminders and health information via electronic message. Intervention and control patients were followed-up every three months by telephone.

The researchers found that between-group differences were statistically significant in HbA1c, postprandial plasma glucose, postprandial insulin, total cholesterol, and low-density lipoprotein cholesterol. In intervention patients, there were significant decreases in levels of glycated hemoglobin, fasting plasma glucose, postprandial plasma glucose, fasting insulin, postprandial insulin, total cholesterol, and low-density lipoprotein cholesterol. Patients only followed by telephone had a significant decrease in systolic blood pressure.

"Regular smartphone communication had a favorable impact on cardiovascular risk factors in patients with type 2 diabetes," the authors write.

Reference

Fang R, Deng X. Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: a randomised controlled trial [published online July 12, 2017]. J Clin Nurs. doi:10.1111/jocn.13962

You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters